Related Experiment Videos
[Clinical study of bacampicillin granules in pediatrics (author's transl)]
The Japanese Journal of Antibiotics
|April 1, 1979
Insights
This study evaluated bacampicillin (BAPC) granules in 20 children with infectious diseases. The antibiotic showed promising results with no observed side effects.
Area of Science:
- Pediatric infectious diseases
- Pharmacology and therapeutics
- Antimicrobial agents
Background:
- Infectious diseases pose a significant health burden in children.
- Effective and safe antibiotic treatments are crucial for pediatric care.
- Bacampicillin is a penicillin derivative with potential antimicrobial activity.
Purpose of the Study:
- To assess the clinical efficacy and safety of bacampicillin (BAPC) granules in pediatric patients.
- To evaluate BAPC granules in treating various common childhood infections.
Main Methods:
- A clinical study involving 20 children diagnosed with infectious diseases.
- Patients received treatment with bacampicillin (BAPC) granules.
- Infections treated included scarlet fever, pertussis, Salmonella enteritis, and acute enteritis.
Main Results:
- Overall clinical results were rated as excellent in 2, good in 9, and fair in 3 cases.
- A total of 4 cases showed poor clinical outcomes.
- No adverse side effects were reported during the study period.
Conclusions:
- Bacampicillin (BAPC) granules demonstrated a generally positive clinical response in children with infectious diseases.
- The safety profile of BAPC granules appears favorable, with no observed side effects.
- Further investigation may be warranted to optimize treatment outcomes for all patients.
Abstract:
Clinical study on bacampicillin (BAPC) granules was performed in 20 children with infectious diseases. Patients treated with BAPC granules were 10 cases of scarlet fever, 3 cases of pertussis, 3 cases of Salmonella enteritis and 4 cases of acute enteritis. Clinical results were excellent in 2, good in 9, fair in 3, poor in 4 and unknown in 2. No side effect was observed.